| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Livial | Organon Pharma (see Schering plough) | C.Mehta & Co Ltd. | 2.5mg | 28 | Tablet | per tablet | KES 2,508.00 |
| Tibon | Questa Care Inc. | Simba Pharmaceutical Ltd. | 2.5mg | 28 | Tablet | per tablet | KES 1,300.00 |
| Tibolone More info | |
|---|---|
| Mode Of Action | Tibolone possesses estrogenic, progestogenic and androgenic activities |
| Drug Indication | Vasomotor symptoms following menopause (natural or surgical). (It shows minimal risks of endometrial hyperplasia or neoplasia as compared to oestrogen). |
| Precautions | Renal / hepatic impairment; signs of thrombo-embolic diseases; diabetes mellitus; epilepsy; migraine; and hypercholesterolaemia |
| Contra-Indications | Unexplained vaginal bleeding; pregnancy and lactation; hormonal dependent tumours; severe hepatic impairment; cerebral vascular disease (history or current); cardiovascular disease (history or current). |
| Side Effects | Vaginal bleeding; GI disturbances; ankle edema; weight changes; dizziness; allergic reactions; increased facial hair; migraine; liver function changes. |
| Dosage | 2.5mg daily |
| Pregnancy Category | Category D |
| Pregnancy Category Description | Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required |